Albion Crown Vct Plc · LSE:CRWC
Albion Crown Vct — Albion Capital Group LLP — Investor Presentation (2021)
19 slides from Albion Crown Vct's investor presentation, 2021
Slide 1: VCT Review, Portfolio and Prospects
VCT Review, Portfolio and Prospects Will Fraser-Allen Managing Partner
Slide 2: Our purpose
Our purpose “We believe that businesses which make new ideas a reality are a force for good. Albion’s purpose is to discover, invest in and support entrepreneurs who create category leading businesses that make a positive contribution to society. In this way we achieve top quartile returns for our i
Slide 3: Albion Capital
Albion Capital c.£880m of funds under management or administration An experienced VCT manager Six VCTs combined with net assets of c. £550m at 30 June 2021 Deep sector knowledge Diverse portfolio of c.70 companies focused on software & healthcare Albion Group institutional entities Specialist instit
Slide 4: Business as usual
Business as usual Albion activity through lockdown: • 9 new investments • 20 follow-on investments • 10 exits completed • 8 new team members recruited • 8 team members have had babies
Slide 5: Ongoing Covid-19 impact
Ongoing Covid-19 impact • Impact of Covid-19 on portfolio appears to be easing. • A number of companies in the portfolio are thriving. • There are still significant macroeconomic uncertainties. • Software, FinTech and Digital Health investments 77% of portfolio (excl. cash) at 30 June 2021. • Shareh
Slide 6: The growing investment team
The growing investment team Will Fraser-Allen Dr Andrew Elder Adam Chirkowski Emil Gigov David Gudgin Rad Hart-George Vikash Hansrani Ed Lascelles Managing Partner Deputy Managing Partner Investment Director Partner Head of Renewable Energy Investment Manager Partner Partner Jane Reddin Dr. Christop
Slide 7: Most recent hires
Most recent hires Leigh Brody joins the investment team after ten years of experience in life sciences. Most recently, she was Executive Director of Platform Strategy at Quell Therapeutics. Leigh has a BSc in Biochemistry from Simmons University and a PhD from Imperial College London. Agnese Palermo
Slide 8: VCTs track record
VCTs track record Returns ahead of target over 1,3,5 and 10 years 1 Year 3 Years 5 Years 10 Years VCT Returns* 17.9% 8.4% 10.8% 8.1% *Average annual performance figures to 30 June 2021 Three of our VCTs paid/will pay special dividends totalling £23m in 2021 The graph sets out the performance of the
Slide 9: Track record
Track record Five year discrete performance 30/06/16 to 30/06/17 to 30/06/18 to 30/06/19 to 30/06/20 to 30/06/17 30/06/18 30/06/19 30/06/20 30/06/21 AADV 9.38% 19.07% 10.67% -1.74% 21.64% AAEV 8.87% 17.32% 9.87% -1.68% 20.77% AATG 7.99% 11.75% 17.46% -3.88% 16.70% AAVC 11.62% 7.66% 10.29% -3.23% 8.6
Slide 10: Portfolio split by sector
Portfolio split by sector Cash Software & 79% of the portfolio is 30% Technology 37% high growth vs. 48% in 2018 21% of the portfolio is 3% asset-based vs. 52% in 10% 2018 Renewable Energy 3% 17% Healthcare incl. Digital Health Software & Tech Business Services & Other Healthcare (incl. Digital Heal
Slide 11: Portfolio split by employee numbers
Portfolio split by employee numbers Renewable Under 20 energy* 5% 14% 21 - 50 29% Companies employing over 50 people represent 52% of the portfolio by value 101+ 38% 51 - 100 14% *Renewable energy schemes do not have employees Total investment portfolio as at 30 June 2021
Slide 12: Portfolio split by revenue
Portfolio split by revenue Early Stage (revenue less than £1 million) 11% Growth (revenue between £1 Companies with revenue million and £5 million) greater than £5 million 22% represent almost 70% of portfolio by value Scale up (revenue over £5 million) 67% Total investment portfolio as at 30 June 2
Slide 13: Top investments - account for 23% of the NAV
Top 3 investments - account for 23% of the NAV at 30 June 2021 Investment Cost Book Revenue Employee date Value Growth Growth Detects financial crime using big data 2017 £10.1m £65.4m >20x 30 to 427 analytics and artificial intelligence. Invested pre- revenue, now 2012 £7.7m £31.7m >£10m 4 to 45 Foc
Slide 14: New deal examples
New deal examples Brytlyt - An early-stage, deep tech company using computation power to accelerate data operations. Gravitee - An open source API platform enabling enterprises to manage APIs for control, access and security. Accelex - Software enabling the automation of data collection, reporting a
Slide 15: Exits
Exits PROCEEDS MULTIPLE IRR Care Homes £51.6m 2.5x 20.1% OmPrompt £8.3m 2.4x 16.7% 20212021 Notable Antenova £5.2m 2.4x 5.7% Notable VCT VCT Exits SBD Exits Automotive £2.1m 2.1x 25.7% Perpetuum* £1.3m 0.5x (12.9%) Elateral* £0.4m 0.1x - £68.9m *inherited investments as part of the takeover of Kings
Slide 16: Prospects
Prospects • We back innovative fast growing companies in B2B software and digital health. • We invest from Seed to Series B growth phases. • Continuing growth potential from the existing software and healthcare portfolio. • Strong investment pipeline of new and follow on investments. • Well diversif
Slide 17: Top Up Offers 2021/2022
Top Up Offers 2021/2022 • Expected launch January 2022. • The prospectus will be on the Albion Capital website • To receive timely launch announcements – PLEASE change your communications preferences to email • Latest updates available on LinkedIn by following Albion Capital Group LLP
Slide 18: Disclaimer
Disclaimer This presentation is issued by Albion Capital Group LLP for information purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, shares in any of the VCTs or funds managed Albion Capital Group LLP or Albion Care Communities Limited. It is provided on a
Slide 19: Q&As
Q&As
Albion Capital Group LLP — Investor Presentation (2021) on 6ix